daratumumab | International Myeloma Foundation

Researchers gather around a table.

Week in Review

September 1

Daratumumab in the News Again: Showing Benefit in Frontline and at Relapse

Adrzej J. Jakubowiak, MD at ASCO 2017

June 7

Daratumumab (DARA) in combination with carfilzomib, lenalidomide, and dexamethasone (KRd) in patients (pts) with newly diagnosed multiple myeloma (MMY1001)

Silver dome made of puzzle pieces next to a blue stethoscope on a blue background

Week in Review

August 25

Summer Updates: More about “dara” …and ideas about what may cause myeloma

Darzalex prescription bottle and box

Week in Review

July 28

Darzalex® (daratumumab): more very good news and a caution

Dr. Durie

Week in Review

June 16

ICER blinks and patients benefit

Week in Review

May 26

ASCO 2016: More excitement about daratumumab (Darzalex®), and tremendous interest in value and costs

Three gifts wrapped

Week in Review

December 17

Three early Christmas presents… but what will be the New Year’s resolutions?

Dr. Durie

Week in Review

August 27

Daratumumab shows great promise in published report today

Subscribe to daratumumab

Give Where Most Needed